These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36681855)

  • 1. A novel machine learning model based on ubiquitin-related gene pairs and clinical features to predict prognosis and treatment effect in colon adenocarcinoma.
    Liang L; Liu L; Mai S; Chen Y
    Eur J Med Res; 2023 Jan; 28(1):41. PubMed ID: 36681855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 3. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
    Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
    Front Immunol; 2022; 13():881359. PubMed ID: 35911752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma.
    Gao H; Xing F
    BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Models for Colon Adenocarcinoma Diagnosis, Prognosis, and Immune Microenvironment Based on 2 Hypoxia-Related Genes: KDM3A and ENO3.
    Kong C; Zheng L; Fang S; Chen M; Lin G; Qiu R; Zhao Z; Chen W; Song J; Yang Y; Ji J
    Technol Cancer Res Treat; 2023; 22():15330338231195494. PubMed ID: 37650153
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and Validation of a Prognostic Model based on 11 E3-related Genes for Colon Cancer Patients.
    JIang W; Dong J; Zhang W; Huang Z; Guo T; Zhang K; Jiang X; Du T
    Curr Pharm Des; 2024; 30(12):935-951. PubMed ID: 38898815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
    Front Oncol; 2022; 12():876660. PubMed ID: 35747790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and verification of a combined immune- and cancer-associated fibroblast related prognostic signature for colon adenocarcinoma.
    Wei J; Ge X; Qian Y; Jiang K; Chen X; Lu W; Yang H; Fu D; Fang Y; Zhou X; Xiao Q; Tang Y; Ding K
    Front Immunol; 2024; 15():1291938. PubMed ID: 38312843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel prognostic signature contributes to precision treatment in colon adenocarcinoma with KRAS mutation.
    Dong W; Zhang H; Li Q; Guan N; Yun C; Zhao H; Zhang F; Zeng Z; Hu Y; Li Q; Yang J; Ma Z; Chen M; Xiao W
    Eur J Cancer Prev; 2023 Nov; 32(6):557-565. PubMed ID: 37310401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
    Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
    Front Immunol; 2021; 12():665002. PubMed ID: 34367132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y; Lu L; Liang X; Chen Y
    World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma.
    Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K
    Front Oncol; 2022; 12():904464. PubMed ID: 35912258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Ubiquitin Related Genes Signature for Predicting Prognosis of Prostate Cancer.
    Song G; Zhang Y; Li H; Liu Z; Song W; Li R; Wei C; Wang T; Liu J; Liu X
    Front Genet; 2021; 12():778503. PubMed ID: 35111198
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma.
    Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F
    Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the six-hormone secretion-related gene signature as a prognostic biomarker for colon adenocarcinoma.
    Jia X; Zhang T; Lv X; Du H; Sun Y; Guan Y
    Cancer Biomark; 2023; 38(4):523-535. PubMed ID: 38143338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients.
    Zheng Y; Wu R; Wang X; Yin C
    Front Public Health; 2022; 10():860381. PubMed ID: 35462848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma.
    Hu G; Li J; Zeng Y; Liu L; Yu Z; Qi X; Liu K; Yao H
    Sci Rep; 2023 Aug; 13(1):13919. PubMed ID: 37626132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.